DYRK1A Signaling in the Brain: Molecular Mechanisms and Neurotransmitter Regulation.
DYRK1A exemplifies precision medicine for dosage-sensitive genes where therapeutic success depends on restoring physiological balance, and Species divergence between rodent and human iPSC models, combined with inter-individual variability, underscores the limitations of current mechanistic models.